Crispr Therapeutics shares owned by Soleus Capital Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Soleus Capital Management
from 13F filings
Historical chart of Soleus Capital Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Soleus Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-06-30 | $2.4M | 42k | 56.14 |
| 2022-12-31 | $894k | 22k | 40.65 |
| 2022-09-30 | $1.4M | 22k | 65.36 |
| 2022-06-30 | $1.3M | 22k | 60.77 |
| 2022-03-31 | $1.4M | 22k | 62.77 |
| 2021-12-31 | $1.7M | 22k | 75.77 |
| 2021-09-30 | $10M | 92k | 111.94 |
| 2021-06-30 | $17M | 103k | 161.89 |
| 2020-12-31 | $1.7M | 11k | 153.07 |
| 2020-09-30 | $853k | 10k | 83.63 |
| 2020-06-30 | $1.3M | 17k | 73.49 |
| 2020-03-31 | $696k | 16k | 42.44 |
| 2019-12-31 | $1.4M | 22k | 60.90 |